Another weight-loss drug, Mounjaro, became available privately in February 2024 and via the NHS in June
This means patients often arrive with brand preferences, asking specifically for Ozempic or Wegovy rather than simply a diabetes drug. The intersection of consumer demand, telehealth convenience, and product visibility creates fertile ground for GLP-1 Drug Marketing innovation
It supports feelings of fullness and can help reduce unnecessary hunger, making it easier to stay consistent with your weight management goals
The best option depends on your budget, device preference, and whether your pharmacy stocks it reliably
The primary objective was to demonstrate the superiority of semaglutide 7.2 mg against placebo on weight loss
At the two-year mark, that figure dropped to 15%